234 related articles for article (PubMed ID: 24562969)
1. Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.
Robinson JD; Howard CD; Pastuzyn ED; Byers DL; Keefe KA; Garris PA
Neurotox Res; 2014 Aug; 26(2):152-67. PubMed ID: 24562969
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.
Howard CD; Daberkow DP; Ramsson ES; Keefe KA; Garris PA
Eur J Neurosci; 2013 Jul; 38(1):2078-88. PubMed ID: 23574406
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.
Howard CD; Keefe KA; Garris PA; Daberkow DP
J Neurochem; 2011 Aug; 118(4):668-76. PubMed ID: 21668447
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
5. Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.
Howard CD; Pastuzyn ED; Barker-Haliski ML; Garris PA; Keefe KA
J Neurochem; 2013 May; 125(4):555-65. PubMed ID: 23480199
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
Tata DA; Raudensky J; Yamamoto BK
Eur J Neurosci; 2007 Aug; 26(3):739-48. PubMed ID: 17686046
[TBL] [Abstract][Full Text] [Related]
9. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
10. A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity.
Friend DM; Keefe KA
Neurosci Lett; 2013 Oct; 555():243-7. PubMed ID: 23994061
[TBL] [Abstract][Full Text] [Related]
11. Modafinil Activates Phasic Dopamine Signaling in Dorsal and Ventral Striata.
Bobak MJ; Weber MW; Doellman MA; Schuweiler DR; Athens JM; Juliano SA; Garris PA
J Pharmacol Exp Ther; 2016 Dec; 359(3):460-470. PubMed ID: 27733628
[TBL] [Abstract][Full Text] [Related]
12. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
Broom SL; Yamamoto BK
Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
[TBL] [Abstract][Full Text] [Related]
13. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
[TBL] [Abstract][Full Text] [Related]
14. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
Zhu JP; Xu W; Angulo JA
Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
[TBL] [Abstract][Full Text] [Related]
15. Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.
Wagner AK; Drewencki LL; Chen X; Santos FR; Khan AS; Harun R; Torres GE; Michael AC; Dixon CE
J Neurochem; 2009 Feb; 108(4):986-97. PubMed ID: 19077052
[TBL] [Abstract][Full Text] [Related]
16. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
Cass WA
J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
[TBL] [Abstract][Full Text] [Related]
17. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
Chauhan H; Killinger BA; Miller CV; Moszczynska A
Int J Mol Sci; 2014 Apr; 15(4):5884-906. PubMed ID: 24717411
[TBL] [Abstract][Full Text] [Related]
18. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
Dluzen DE; McDermott JL; Darvesh AS
Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
[TBL] [Abstract][Full Text] [Related]
19. Running wheel exercise before a binge regimen of methamphetamine does not protect against striatal dopaminergic damage.
O'dell SJ; Marshall JF
Synapse; 2014 Sep; 68(9):419-25. PubMed ID: 24899064
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.
Yorgason JT; Hedges DM; Obray JD; Jang EY; Bills KB; Woodbury M; Williams B; Parsons MJ; Andres MA; Steffensen SC
Psychopharmacology (Berl); 2020 May; 237(5):1317-1330. PubMed ID: 31965252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]